IpgB1 and IpgB2, two homologous effectors secreted via the Mxi-Spa type III secretion apparatus, cooperate to mediate polarized cell invasion and inflammatory potential of Shigella flexenri

Microbes and Infection

Volumn 10, Issue 3, 2008, Pages 260-268

  Hachani, Abderrahman ^a   Biskri, Latefa ^a   Rossi, Giacomo ^b   Marty, Allison ^c,d   Ménard, Robert ^c   Sansonetti, Philippe ^c,d   Parsot, Claude ^c,d   Van Nhieu, Guy Tran ^c,d   Bernardini, Maria Lina ^e   Allaoui, Abdelmounaaïm ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF CAMERINO   (Italy)

^c INSTITUT PASTEUR   (France)

^d INSERM   (France)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Invasion; Shigella; Tight junction; Type III secretion

Indexed keywords

CHAPERONE; CHAPERONE SPA15; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; CELL INVASION; CELL STRAIN CACO 2; CONTROLLED STUDY; GENE; GENE MUTATION; GUINEA PIG; HELA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; INFLAMMATION; IPGB1 GENE; IPGB2 GENE; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SHIGELLA; SHIGELLA FLEXENRI; TYPE III SECRETION SYSTEM; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CACO-2 CELLS; DYSENTERY, BACILLARY; FEMALE; HELA CELLS; HUMANS; INFLAMMATION; MICE; MICE, INBRED BALB C; MOLECULAR CHAPERONES; MOLECULAR SEQUENCE DATA; POINT MUTATION; RAC1 GTP-BINDING PROTEIN; SEQUENCE ALIGNMENT; SHIGELLA FLEXNERI; VIRULENCE;

BACTERIA (MICROORGANISMS); CAVIA; MURINAE; NEGIBACTERIA; SHIGELLA; SHIGELLA FLEXNERI;

EID: 40949156258     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.11.011     Document Type: Article

References (30)

1. Cornelis G.-R. The type III secretion injectisome. Nat. Rev. Microbiol. 4 (2006) 811-825
2. Hueck C.-J. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62 (1998) 379-433
3. Parsot C. Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors. FEMS Microbiol. Lett. 252 (2005) 11-18
4. Allaoui A., Sansonetti P.-J., and Parsot C. MxiJ, a lipoprotein involved in secretion of Shigella Ipa invasins, is homologous to YscJ, a secretion factor of the Yersinia Yop proteins. J. Bacteriol. 174 (1992) 7661-7669
5. Allaoui A., Sansonetti P.-J., and Parsot C. MxiD, an outer membrane protein necessary for the secretion of the Shigella flexneri lpa invasins. Mol. Microbiol. 7 (1993) 59-68
6. Blocker A., Jouihri N., Larquet E., Gounon P., Ebel F., Parsot C., Sansonetti P.J., and Allaoui A. Structure and composition of the Shigella flexneri 'needle complex' a part of its type III secretion. Mol. Microbiol. 39 (2001) 652-663
7. Blocker A., Gounon P., Larquet E., Niebuhr K., Cabiaux V., Parsot C., and Sansonetti P.-J. The tripartite type III secreton of Shigella flexneri inserts IpaB and IpaC into host membranes. J. Cell Biol. 147 (1999) 683-693
8. Philpott D.-J., Yamaoka S., Israel A., and Sansonetti P.-J. Invasive Shigella flexneri activates NF-kappaB through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells. J. Immunol. 165 (2000) 903-914
9. Sansonetti P.-J. The innate signaling of dangers and the dangers of innate signaling. Nat. Immunol. 7 (2006) 1237-1242
10. Mounier J., Vasselon T., Hellio R., Lesourd M., and Sansonetti P.-J. Shigella flexneri enters human colonic Caco-2 epithelial cells through the basolateral pole. Infect. Immun. 60 (1992) 237-248
11. Wells C.-L., Van de Westerlo E.-M., Jechrek R.-P., Haines H.-K., and Erlandsen S.-L. Cytochalasin-induced actin disruption of polarized enterocytes can augment internalization of bacteria. Infect. Immun. 66 (1998) 2410-2419
12. Ohya K., Handa Y., Ogawa M., Suzuki M., and Sasakawa C. IpgB1 is a novel Shigella effector protein involved in bacterial invasion of Host cells. Its activity is to promote membrane ruffling via Rac1 and Cdc42 activation. J. Biol. Chem. 280 (2005) 24022-24034
13. Alto N., Shao M.-F., Lazar C.-S., Brost R.-L., Chua G., Mattoo S., McMahon S.-A., Ghosh P., Hughes T.-R., Boone C., and Dixon J.-E. Identification of a bacterial type III effector family with G protein mimicry functions. Cell 124 (2006) 133-145
14. Yutaka H., Suzuki M., Ohya K., Iwai I.-H., Ishijima N., Koleske A.-J., Fukui Y., and Sasakawa C. Shigella IpgB1 promotes bacterial entry through the ELMO-Dock180 machinery. Nat. Cell. Biol. 1 (2007) 121-128
15. Buchrieser C., Glaser P., Rusniok C., Nedjari H., D'Hauteville H., Kunst F., Sansonetti P.-J., and Parsot C. The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri. Mol. Microbiol. 38 (2000) 760-771
16. Page A.-L., Sansonetti P.-J., and Parsot C. Spa15 of Shigella flexneri, a third type of chaperone in the type III secretion pathway. Mol. Microbiol. 43 (2002) 1533-1542
17. Sansonetti P.-J., Ryter A., Clerc P., Maurelli A.-T., and Mounier J. Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact haemolysis. Infect. Immun. 51 (1986) 461-469
18. Van Nhieu G.-T., Clair C., Bruzzone R., Mesnil M., Sansonetti P.-J., and Combettes L. Connexin dependent inter-cellular communication increases invasion and dissemination of Shigella in epithelial cells. Nat. Cell Biol. 5 (2003) 720-726
19. Sereny B., Tenner C., and Racz P. Immunogenicity of living attenuated shigellae. Acta. Microbiol. Acad. Sci. Hung. 18 (1971) 239-245
20. Mallett C.-P., Van de Verg L.-L., Collins H.-H., and Hale T.-L. Evaluation of Shigella vaccine safety and efficacy in an intranasal challenged mouse model. Vaccine 11 (1993) 190-196
21. Cersini A., Martino M.-C., Martini I., Rossi G., and Bernardini M.-L. Analysis of virulence and inflammatory potential of Shigella flexneri purine biosynthesis mutants. Infect. Immun. 71 (2003) 7002-7013
22. Parsot C., Ageron E., Penno C., Mavris M., Jamoussi K., D'Hauteville H., Sansonetti P.-J., and Demers B. A secreted anti-activator, OspD1, and its chaperone Spa15, are involved in the control of transcription by the type III secretion apparatus activity in Shigella flexneri. Mol. Microbiol. 56 (2005) 1627-1635
23. Sakaguchi T., Kohler H., Gu X., McCormick B.-A., and Reinecker H.-C. Shigella flexneri regulates tight junction-associated proteins in human intestinal epithelial cells. Cell. Microbiol. 4 (2002) 367-381
24. Braga V.-M. Cell-cell adhesion and signalling. Curr. Opin. Cell. Biol. 14 (2002) 546-556
25. Dean P., and Kenny B. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Mol. Microbiol. 54 (2004) 665-675
26. Saadat I., Higashi H., Obuse C., Umeda M., Murata-Kamiya N., Saito Y., Lu H., Ohnishi N., Azuma T., Suzuki A., Ohno S., and Hatakeyama M. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 447 (2007) 330-333
27. Phalipon A., Kaufmann M., Michetti P., Cavaillon J.-M., Huerre M., Sansonetti P.-J., and Kraehenbuhl J.P. Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharides protects murine experimental shigellosis. J. Exp. Med. 182 (1995) 769-772
28. de Silva D.-G., Mendis L.-N., Sheron N., Alexander G.-J., Candy D.-C., Chart H., and Rowe B. Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection. Gut 34 (1993) 194-198
29. D'Hauteville H., Khan S., Maskell D.-J., Kussak A., Weintraub A., Mathison J., Ulevitch R.-J., Wuscher N., Parsot C., and Sansonetti P.-J. Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium. J. Immunol. 168 (2002) 5240-5251
30. Clayburgh D.-R., Rosen S., Witkowski E.-D., Wang F., Blair S., Dudek S., Garcia J.-G., Alverdy J.C., and Turner J.-R. A differentiation-dependent splice variant of myosin light chain kinase, MLCK1, regulates epithelial tight junction permeability. J. Biol. Chem. 279 (2004) 55506-55513